- Home
- CLST vs VRCA Comparison
CLST vs VRCA Comparison
Compare CLST & VRCA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLST
- VRCA
- Stock Information
- Founded
- CLST 1922
- VRCA 2013
- Country
- CLST United States
- VRCA United States
- Employees
- CLST N/A
- VRCA N/A
- Industry
- CLST
- VRCA Biotechnology: Pharmaceutical Preparations
- Sector
- CLST
- VRCA Health Care
- Exchange
- CLST Nasdaq
- VRCA Nasdaq
- Market Cap
- CLST 48.8M
- VRCA 43.0M
- IPO Year
- CLST N/A
- VRCA 2018
- Fundamental
- Price
- CLST $11.85
- VRCA $0.53
- Analyst Decision
- CLST
- VRCA Hold
- Analyst Count
- CLST 0
- VRCA 5
- Target Price
- CLST N/A
- VRCA $6.00
- AVG Volume (30 Days)
- CLST 5.1K
- VRCA 263.8K
- Earning Date
- CLST 04-24-2025
- VRCA 05-13-2025
- Dividend Yield
- CLST N/A
- VRCA N/A
- EPS Growth
- CLST N/A
- VRCA N/A
- EPS
- CLST 0.57
- VRCA N/A
- Revenue
- CLST $11,257,000.00
- VRCA $7,179,000.00
- Revenue This Year
- CLST N/A
- VRCA $127.85
- Revenue Next Year
- CLST N/A
- VRCA $105.09
- P/E Ratio
- CLST $21.12
- VRCA N/A
- Revenue Growth
- CLST 200.91
- VRCA N/A
- 52 Week Low
- CLST $10.67
- VRCA $0.38
- 52 Week High
- CLST $12.40
- VRCA $9.36
- Technical
- Relative Strength Index (RSI)
- CLST 62.86
- VRCA 43.40
- Support Level
- CLST $11.62
- VRCA $0.49
- Resistance Level
- CLST $12.00
- VRCA $0.73
- Average True Range (ATR)
- CLST 0.11
- VRCA 0.07
- MACD
- CLST 0.02
- VRCA -0.01
- Stochastic Oscillator
- CLST 100.00
- VRCA 10.77
About CLST Catalyst Bancorp Inc.
Catalyst Bancorp Inc is a bank holding company. Through its subsidiary, which is a federally chartered community-oriented savings bank, it is engaged in attracting deposits from the general public and using those funds to invest in loans and securities. The sources of funds are customer deposits, repayments of loans, maturities of investments, and funds borrowed from outside sources, which are used for the origination of loans. It derives income principally from interest earned on loans and investment securities and, to a lesser extent, from fees received in connection with the origination of loans, service charges on deposit accounts, and other services.
About VRCA Verrica Pharmaceuticals Inc.
Verrica Pharmaceuticals Inc is a dermatology therapeutics company engaged in the development and commercialization of novel treatments that provide a meaningful benefit for people living with skin diseases. Its product candidate, VP-102, is developed for the treatment of molluscum contagiosum, or molluscum, a contagious and pediatric viral skin disease, and common warts.